Promising new assays and technologies for the diagnosis and management of infectious diseases

Clinical Infectious Diseases

Volumn 56, Issue 7, 2013, Pages 996-1002

  Mitsuma, S F ^a   Mansour, M K ^a   Dekker, J P ^a   Kim, J ^a   Rahman, M Z ^a   Tweed Kent, A ^a   Schuetz, P ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Gene expression profiling; MALDI TOF MS; Mass spectrometry; Procalcitonin; Sepsis

Indexed keywords

APTAMER; CORTICOSTEROID; NUCLEIC ACID; PROCALCITONIN;

ANALYZER; ANTIBIOTIC THERAPY; ASSAY; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DEVICE INFECTION; GENE EXPRESSION PROFILING; IONIZATION CHAMBER; LEUKOCYTE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SERUM; TECHNOLOGY;

CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASES; HUMANS;

EID: 84875044288     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1014     Document Type: Review

References (49)

1. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-96.
2. Proulx N, Frechette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005; 98: 291-8.
3. Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibioticresistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 155-64.
4. Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009; 49: 1175-84.
5. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004; 32: 1715-21.
6. Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011; 37: 796-800.
7. Becker KL. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512-25.
8. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011; 171: 1322-31.
9. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012; 55: 651-62.
10. Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med 2011; 39: 1792-9.
11. Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012; 172: 715-22.
12. Gilbert D. Serum procalcitonin levels: comment on "effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in 'real life'". Arch Intern Med 2012; 172: 722-3.
13. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011; 39: 2048-58.
14. Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet 2011; 12: 87-98.
15. Ozsolak F, Milos PM. Single-molecule direct RNA sequencing without cDNA synthesis. Wiley Interdiscip Rev RNA 2011; 2: 565-70.
16. Ramilo O, Allman W, Chung W, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007; 109: 2066-77.
17. Zaas AK, Chen M, Varkey J, et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 2009; 6: 207-17.
18. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 2007; 176: 676-84.
19. Tang BM, Huang SJ, McLean AS. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 2010; 14:R237.
20. Kamal AH, Loprinzi CL, Reynolds C, et al. Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score. Oncologist 2011; 16: 1359-66.
21. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010; 362: 1890-900.
22. Dekker JP, Branda JA. MALDI-TOF mass spectrometry in the clinical microbiology laboratory. Clin Microbiol Newsl 2011; 33: 87-93.
23. Sauer S, Kliem M. Mass spectrometry tools for the classification and identification of bacteria. Nat Rev Microbiol 2010; 8: 74-82.
24. Sauer S, Freiwald A, Maier T, et al. Classification and identification of bacteria by mass spectrometry and computational analysis. PLoS One 2008; 3:e2843.
25. Freiwald A, Sauer S. Phylogenetic classification and identification of bacteria by mass spectrometry. Nat Protoc 2009; 4: 732-42.
26. Ho YP, Reddy PM. Identification of pathogens by mass spectrometry. Clin Chem 2010; 56: 525-36.
27. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 2010; 48: 1549-54.
28. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-offlight mass spectrometry. PLoS One 2009; 4:e8041.
29. Stevenson LG, Drake SK, Murray PR. Rapid identification of bacteria in positive blood culture broths bymatrix-assisted laser desorption ionizationtime of flight mass spectrometry. J Clin Microbiol 2010; 48: 444-7.
30. Prod'hom G, Bizzini A, Durussel C, Bille J, Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 2010; 48: 1481-3.
31. Ferreira L, Sanchez-Juanes F, Gonzalez-Avila M, et al. Direct identification of urinary tract pathogens from urine samples by matrixassisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48: 2110-5.
32. Horton G. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006; 52: 1223-37.
33. Mellmann A, Cloud J, Maier T, et al. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 2008; 46: 1946-54.
34. Pignone M, Greth KM, Cooper J, Emerson D, Tang J. Identification of mycobacteria by matrix-assisted laser desorption ionization-time-offlight mass spectrometry. J Clin Microbiol 2006; 44: 1963-70.
35. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-10.
36. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-22.
37. Dua P, Kim S, Lee DK. Patents on SELEX and therapeutic aptamers. Recent Pat DNA Gene Seq 2008; 2: 172-86.
38. Jenison RD, Gill SC, Pardi A, Polisky B. High-resolution molecular discrimination by RNA. Science 1994; 263: 1425-9.
39. Hamula CL, Zhang H, Guan LL, Li XF, Le XC. Selection of aptamers against live bacterial cells. Anal Chem 2008; 80: 7812-9.
40. Hamula CL, Le XC, Li XF. DNA aptamers binding to multiple prevalent M-types of Streptococcus pyogenes. Anal Chem 2011; 83: 3640-7.
41. Lee YJ, Han SR, Maeng JS, Cho YJ, Lee SW. In vitro selection of Escherichia coli O157:H7-specific RNA aptamer. Biochem Biophys Res Commun 2012; 417: 414-20.
42. Cao X, Li S, Chen L, et al. Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res 2009; 37: 4621-8.
43. Dwivedi HP, Smiley RD, Jaykus LA. Selection and characterization of DNA aptamers with binding selectivity to Campylobacter jejuni using whole-cell SELEX. Appl Microbiol Biotechnol 2010; 87: 2323-34.
44. Duan N, Wu S, Chen X, Huang Y, Wang Z. Selection and identification of a DNA aptamer targeted to Vibrio parahemolyticus. J Agric Food Chem 2012; 60: 4034-8.
45. Duan N, Wu S, Zhu C, et al. Dual-color upconversion fluorescence and aptamer-functionalized magnetic nanoparticles-based bioassay for the simultaneous detection of Salmonella Typhimurium and Staphylococcus aureus. Anal Chim Acta 2012; 723: 1-6.
46. Hyeon JY, Chon JW, Choi IS, Park C, Kim DE, Seo KH. Development of RNA aptamers for detection of Salmonella Enteritidis. J Microbiol Methods 2012; 89: 79-82.
47. Yan AC, Levy M. Aptamers and aptamer targeted delivery. RNA Biol 2009; 6: 316-20.
48. Mairal T, Ozalp VC, Lozano Sanchez P, Mir M, Katakis I, O'Sullivan CK. Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 2008; 390: 989-1007.
49. Gopinath SC, Misono TS, Kawasaki K, et al. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J Gen Virol 2006; 87(Pt 3): 479-87.